The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection

Human monoclonal antibodies (hmAbs) that protect against all influenza A and B strains are considered the road to universal influenza vaccines. Based on publicly-available data, we analyze the mechanistic and structural basis of pan-influenza protection by CR9114, a hemagglutinin (HA) stem-reactive...

Full description

Bibliographic Details
Main Authors:	Anna L. Beukenhorst, Jacopo Frallicciardi, Clarissa M. Koch, Jaco M. Klap, Angela Phillips, Michael M. Desai, Kanin Wichapong, Gerry A. F. Nicolaes, Wouter Koudstaal, Galit Alter, Jaap Goudsmit
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Virology
Subjects:	broadly neutralizing antibodies influenza virus pan-influenza protection CR9114 correlate of protection antiviral therapies
Online Access:	https://www.frontiersin.org/articles/10.3389/fviro.2022.1049134/full

Similar Items

Corrigendum: The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection
by: Anna L. Beukenhorst, et al.
Published: (2023-01-01)

Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization
by: Joan E. M. van der Lubbe, et al.
Published: (2017-06-01)

Salmonella-Delivered COBRA-HA1 Antigen Derived from H1N1 Hemagglutinin Sequences Elicits Broad-Spectrum Protection Against Influenza A Subtypes
by: Ram Prasad Aganja, et al.
Published: (2024-01-01)

Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses
by: Chenchen Jiao, et al.
Published: (2023-02-01)

Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
by: Sabari Nath Neerukonda, et al.
Published: (2020-07-01)

Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses
by: Peipei Wu, et al.
Published: (2017-11-01)

Progress towards the Development of a Universal Influenza Vaccine
by: Wen-Chien Wang, et al.
Published: (2022-07-01)

Hemagglutinin consensus-based prophylactic approaches to overcome influenza virus diversity
by: Giuseppe Andrea Sautto, et al.
Published: (2019-10-01)

Cationic Perylene Antivirals with Aqueous Solubility for Studies In Vivo
by: Anna A. Shtro, et al.
Published: (2022-09-01)

In the Shadow of Hemagglutinin: A Growing Interest in Influenza Viral Neuraminidase and Its Role as a Vaccine Antigen
by: Teddy John Wohlbold, et al.
Published: (2014-06-01)

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial
by: Eva van Doorn, et al.
Published: (2017-04-01)

<italic toggle="yes">In Vivo</italic> Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression
by: Silvie Van den Hoecke, et al.
Published: (2021-08-01)

M2-based influenza vaccines: recent advances and clinical potential
by: Annasaheb Kolpe, et al.
Published: (2017-02-01)

A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection
by: Dian Zeng, et al.
Published: (2022-06-01)

Prevalence of circulating antibodies against hemagglutinin of influenza viruses in epidemic season 2021/2022 in Poland
by: Katarzyna Kondratiuk, et al.
Published: (2024-02-01)

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
by: Carolyn M. Boudreau, et al.
Published: (2019-03-01)

Universal Influenza Vaccines, a Dream to Be Realized Soon
by: Han Zhang, et al.
Published: (2014-04-01)

Etymologia: Hemagglutinin and Neuraminidase
by: Ronnie Henry, et al.
Published: (2018-10-01)

Indirect Protection from Vaccinating Children against Influenza A Virus Infection in Households
by: Tim K. Tsang, et al.
Published: (2022-09-01)

Immunogenicity of chimeric hemagglutinins delivered by an orf virus vector platform against swine influenza virus
by: Gabriela Mansano do Nascimento, et al.
Published: (2024-02-01)

Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus
by: Jingjin Huang, et al.
Published: (2020-12-01)

A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release
by: Seiya Yamayoshi, et al.
Published: (2017-03-01)

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for <italic toggle="yes">In Vivo</italic> Protection in a Serum Transfer Mouse Challenge Model
by: Henning Jacobsen, et al.
Published: (2017-11-01)

An Adenovirus-Vectored Influenza Vaccine Induces Durable Cross-Protective Hemagglutinin Stalk Antibody Responses in Mice
by: Eun Hye Kim, et al.
Published: (2017-08-01)

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
by: Wen-Chun Liu, et al.
Published: (2019-04-01)

Immunogenicity Measures of Influenza Vaccines: A Study of 1164 Registered Clinical Trials
by: Alexander Domnich, et al.
Published: (2020-06-01)

Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines
by: Joshua G. Petrie, et al.
Published: (2018-03-01)

Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus?
by: Irina Kiseleva, et al.
Published: (2019-06-01)

Strengthening the Effectiveness of the Candidate Influenza Vaccine by Combining Conserved Sequences of Hemagglutinin and M2 protein
by: L. M. Tsybalova, et al.
Published: (2017-06-01)

Soluble Recombinant Hemagglutinin Protein of H1N1pdm09 Influenza Virus Elicits Cross-Protection Against a Lethal H5N1 Challenge in Mice
by: Shinya Yamada, et al.
Published: (2019-09-01)

HA antibody mediated FcγRIIIa activity is both dependent on FcR engagement and interactions between HA and sialic acids
by: Freek Cox
Published: (2016-09-01)

Vaccine approaches conferring cross-protection against influenza viruses
by: Sai V Vemula, et al.
Published: (2017-11-01)

Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines
by: Alexandra Rak, et al.
Published: (2023-11-01)

Mucosal correlates of protection after influenza viral challenge of vaccinated and unvaccinated healthy volunteers
by: Rachel Bean, et al.
Published: (2024-02-01)

Group 1 and group 2 hemagglutinin stalk antibody response according to age
by: Laura Sánchez-de Prada, et al.
Published: (2023-05-01)

Hemagglutinin Receptor Binding of a Human Isolate of Influenza A(H10N8) Virus
by: Irene Ramos, et al.
Published: (2015-07-01)

An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains
by: Weina Sun, et al.
Published: (2019-09-01)

Hemagglutinin Antibodies in the Polish Population during the 2019/2020 Epidemic Season
by: Karol Szymański, et al.
Published: (2023-03-01)

A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration
by: Anna L. Beukenhorst, et al.
Published: (2024-02-01)

The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity
by: E Gianchecchi, et al.
Published: (2019-05-01)